SMTL ID : 7fh0.1

Crystallographic structure of two neutralizing nanobodies in complex with SARS-CoV-2 spike receptor-binding Domain (RBD)

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 3.20 Å
Oligo State
hetero-1-2-mer
Ligands
1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
3 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
2 x GOL: GLYCEROL(Non-functional Binders)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Ma, H. et al., Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron. Cell Res. (2022)
Release Date
2022-08-03
Peptides
Spike protein S1,Spike protein S1: A
nanobodies aRBD-2-7: BC
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B
C
C

Spike protein S1,Spike protein S1

nanobodies aRBD-2-7

Toggle Identical (BC)